EGFR mutations in US Hispanic versus non-Hispanic white patients with lung adenocarcinoma

Wei Zhang, Elizabeth B. McQuitty, Randall Olsen, Hongxin Fan, Heather Hendrickson, Fermin O. Tio, Keith Newton, Philip T. Cagle, Jaishree Jagirdar

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Context.bull;-Lung cancer is the leading cause of cancer deaths worldwide. First-generation tyrosine kinase inhibitors improve progression-free survival in lung cancers with epidermal growth factor receptor (EGFR) mutations. EGFR mutations occur predominantly in exons 19 and 21 in lung adenocarcinomas of Asians (~30%), whites (~15%), and African Americans (~19%). However, minimal information exists on the prevalence or type of genetic changes that occur in lung cancers in US Hispanic patients. We investigated the EGFR mutation frequency in primary lung adenocarcinomas in US Hispanics compared with non-Hispanic whites. Objective.-To evaluate EGFR mutations in lung adenocarcinomas from US Hispanic patients compared with those from non-Hispanic white patients. Design.-DNA samples were extracted from paraffinembedded tissue of consecutive lung adenocarcinomas from 83 patients. Samples were collected from 40 Hispanics and 43 non-Hispanic whites. Mutations in EGFR were analyzed using a custom assay. Results.-Fourteen of 83 patients (16.9%) had EGFR mutations in their tumor DNA, including 6 of 40 Hispanics (15.0%) and 8 of 43 non-Hispanic whites (18.6%). No association with age, sex, or tumor stage was identified. Smoking history could not be obtained for most of the 83 patients, although 8 of the 11 patients with EGFR mutations for whom smoking history was obtained were nonsmokers. Most of the tumors with EGFR mutations (12 of 14; 85.7%) were acinar with lepidic or papillary subtypes. EGFR mutations occurred in exon 19 (42.8%), exon 18 (28.6%), exon 20 (28.6%), and exon 21 (14.3%). Two cases had 2 mutations identified in different exons. Conclusion.-The frequency of EGFR mutations is similar in US Hispanics compared with non-Hispanic whites.

Original languageEnglish (US)
Pages (from-to)543-545
Number of pages3
JournalArchives of Pathology and Laboratory Medicine
Volume138
Issue number4
DOIs
StatePublished - 2014

Fingerprint

Hispanic Americans
Epidermal Growth Factor Receptor
Mutation
Exons
Lung Neoplasms
Neoplasms
Smoking
History
Adenocarcinoma of lung
DNA
Mutation Rate
African Americans
Protein-Tyrosine Kinases
Disease-Free Survival
Cause of Death

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Zhang, W., McQuitty, E. B., Olsen, R., Fan, H., Hendrickson, H., Tio, F. O., ... Jagirdar, J. (2014). EGFR mutations in US Hispanic versus non-Hispanic white patients with lung adenocarcinoma. Archives of Pathology and Laboratory Medicine, 138(4), 543-545. https://doi.org/10.5858/arpa.2013-0311-OA

EGFR mutations in US Hispanic versus non-Hispanic white patients with lung adenocarcinoma. / Zhang, Wei; McQuitty, Elizabeth B.; Olsen, Randall; Fan, Hongxin; Hendrickson, Heather; Tio, Fermin O.; Newton, Keith; Cagle, Philip T.; Jagirdar, Jaishree.

In: Archives of Pathology and Laboratory Medicine, Vol. 138, No. 4, 2014, p. 543-545.

Research output: Contribution to journalArticle

Zhang, W, McQuitty, EB, Olsen, R, Fan, H, Hendrickson, H, Tio, FO, Newton, K, Cagle, PT & Jagirdar, J 2014, 'EGFR mutations in US Hispanic versus non-Hispanic white patients with lung adenocarcinoma', Archives of Pathology and Laboratory Medicine, vol. 138, no. 4, pp. 543-545. https://doi.org/10.5858/arpa.2013-0311-OA
Zhang, Wei ; McQuitty, Elizabeth B. ; Olsen, Randall ; Fan, Hongxin ; Hendrickson, Heather ; Tio, Fermin O. ; Newton, Keith ; Cagle, Philip T. ; Jagirdar, Jaishree. / EGFR mutations in US Hispanic versus non-Hispanic white patients with lung adenocarcinoma. In: Archives of Pathology and Laboratory Medicine. 2014 ; Vol. 138, No. 4. pp. 543-545.
@article{f6e5efd703e14108b2032b1e163d1c87,
title = "EGFR mutations in US Hispanic versus non-Hispanic white patients with lung adenocarcinoma",
abstract = "Context.bull;-Lung cancer is the leading cause of cancer deaths worldwide. First-generation tyrosine kinase inhibitors improve progression-free survival in lung cancers with epidermal growth factor receptor (EGFR) mutations. EGFR mutations occur predominantly in exons 19 and 21 in lung adenocarcinomas of Asians (~30{\%}), whites (~15{\%}), and African Americans (~19{\%}). However, minimal information exists on the prevalence or type of genetic changes that occur in lung cancers in US Hispanic patients. We investigated the EGFR mutation frequency in primary lung adenocarcinomas in US Hispanics compared with non-Hispanic whites. Objective.-To evaluate EGFR mutations in lung adenocarcinomas from US Hispanic patients compared with those from non-Hispanic white patients. Design.-DNA samples were extracted from paraffinembedded tissue of consecutive lung adenocarcinomas from 83 patients. Samples were collected from 40 Hispanics and 43 non-Hispanic whites. Mutations in EGFR were analyzed using a custom assay. Results.-Fourteen of 83 patients (16.9{\%}) had EGFR mutations in their tumor DNA, including 6 of 40 Hispanics (15.0{\%}) and 8 of 43 non-Hispanic whites (18.6{\%}). No association with age, sex, or tumor stage was identified. Smoking history could not be obtained for most of the 83 patients, although 8 of the 11 patients with EGFR mutations for whom smoking history was obtained were nonsmokers. Most of the tumors with EGFR mutations (12 of 14; 85.7{\%}) were acinar with lepidic or papillary subtypes. EGFR mutations occurred in exon 19 (42.8{\%}), exon 18 (28.6{\%}), exon 20 (28.6{\%}), and exon 21 (14.3{\%}). Two cases had 2 mutations identified in different exons. Conclusion.-The frequency of EGFR mutations is similar in US Hispanics compared with non-Hispanic whites.",
author = "Wei Zhang and McQuitty, {Elizabeth B.} and Randall Olsen and Hongxin Fan and Heather Hendrickson and Tio, {Fermin O.} and Keith Newton and Cagle, {Philip T.} and Jaishree Jagirdar",
year = "2014",
doi = "10.5858/arpa.2013-0311-OA",
language = "English (US)",
volume = "138",
pages = "543--545",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "4",

}

TY - JOUR

T1 - EGFR mutations in US Hispanic versus non-Hispanic white patients with lung adenocarcinoma

AU - Zhang, Wei

AU - McQuitty, Elizabeth B.

AU - Olsen, Randall

AU - Fan, Hongxin

AU - Hendrickson, Heather

AU - Tio, Fermin O.

AU - Newton, Keith

AU - Cagle, Philip T.

AU - Jagirdar, Jaishree

PY - 2014

Y1 - 2014

N2 - Context.bull;-Lung cancer is the leading cause of cancer deaths worldwide. First-generation tyrosine kinase inhibitors improve progression-free survival in lung cancers with epidermal growth factor receptor (EGFR) mutations. EGFR mutations occur predominantly in exons 19 and 21 in lung adenocarcinomas of Asians (~30%), whites (~15%), and African Americans (~19%). However, minimal information exists on the prevalence or type of genetic changes that occur in lung cancers in US Hispanic patients. We investigated the EGFR mutation frequency in primary lung adenocarcinomas in US Hispanics compared with non-Hispanic whites. Objective.-To evaluate EGFR mutations in lung adenocarcinomas from US Hispanic patients compared with those from non-Hispanic white patients. Design.-DNA samples were extracted from paraffinembedded tissue of consecutive lung adenocarcinomas from 83 patients. Samples were collected from 40 Hispanics and 43 non-Hispanic whites. Mutations in EGFR were analyzed using a custom assay. Results.-Fourteen of 83 patients (16.9%) had EGFR mutations in their tumor DNA, including 6 of 40 Hispanics (15.0%) and 8 of 43 non-Hispanic whites (18.6%). No association with age, sex, or tumor stage was identified. Smoking history could not be obtained for most of the 83 patients, although 8 of the 11 patients with EGFR mutations for whom smoking history was obtained were nonsmokers. Most of the tumors with EGFR mutations (12 of 14; 85.7%) were acinar with lepidic or papillary subtypes. EGFR mutations occurred in exon 19 (42.8%), exon 18 (28.6%), exon 20 (28.6%), and exon 21 (14.3%). Two cases had 2 mutations identified in different exons. Conclusion.-The frequency of EGFR mutations is similar in US Hispanics compared with non-Hispanic whites.

AB - Context.bull;-Lung cancer is the leading cause of cancer deaths worldwide. First-generation tyrosine kinase inhibitors improve progression-free survival in lung cancers with epidermal growth factor receptor (EGFR) mutations. EGFR mutations occur predominantly in exons 19 and 21 in lung adenocarcinomas of Asians (~30%), whites (~15%), and African Americans (~19%). However, minimal information exists on the prevalence or type of genetic changes that occur in lung cancers in US Hispanic patients. We investigated the EGFR mutation frequency in primary lung adenocarcinomas in US Hispanics compared with non-Hispanic whites. Objective.-To evaluate EGFR mutations in lung adenocarcinomas from US Hispanic patients compared with those from non-Hispanic white patients. Design.-DNA samples were extracted from paraffinembedded tissue of consecutive lung adenocarcinomas from 83 patients. Samples were collected from 40 Hispanics and 43 non-Hispanic whites. Mutations in EGFR were analyzed using a custom assay. Results.-Fourteen of 83 patients (16.9%) had EGFR mutations in their tumor DNA, including 6 of 40 Hispanics (15.0%) and 8 of 43 non-Hispanic whites (18.6%). No association with age, sex, or tumor stage was identified. Smoking history could not be obtained for most of the 83 patients, although 8 of the 11 patients with EGFR mutations for whom smoking history was obtained were nonsmokers. Most of the tumors with EGFR mutations (12 of 14; 85.7%) were acinar with lepidic or papillary subtypes. EGFR mutations occurred in exon 19 (42.8%), exon 18 (28.6%), exon 20 (28.6%), and exon 21 (14.3%). Two cases had 2 mutations identified in different exons. Conclusion.-The frequency of EGFR mutations is similar in US Hispanics compared with non-Hispanic whites.

UR - http://www.scopus.com/inward/record.url?scp=84898411296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898411296&partnerID=8YFLogxK

U2 - 10.5858/arpa.2013-0311-OA

DO - 10.5858/arpa.2013-0311-OA

M3 - Article

C2 - 23937608

AN - SCOPUS:84898411296

VL - 138

SP - 543

EP - 545

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 4

ER -